What's new
Fantasy Football - Footballguys Forums

Welcome to Our Forums. Once you've registered and logged in, you're primed to talk football, among other topics, with the sharpest and most experienced fantasy players on the internet.

Stock Thread (3 Viewers)

ZNGA was a recommendation here.  It's up 24% since the end of December.  Does anyone have a price target on it?  I'm looking to reduce the number of stocks I'm hold back into the double digits but don't want to cull any potential 2 baggers.
That was one I got from the Motley Fool. 

 
Do you mean BLDP, Todem’s hydrogen pick?
No..this is a penny stock that is in the ecommerce, fintech for cannabis. They are working with Hyper which is one the leading payment and banking companies. Hyper is powering Dutchie which is backed by Snoops VC firm, Casa Verde.  I've worked with these companies in the cannabis space, so I'm extremely interested. 

 
Big League Chew said:
not yuge numbers but a ceo bought $0.02+5,000,000 for BSPK    CBD company

Bespoke Extracts, Inc. is engaged in developing of natural cannabidiol (CBD) products in the form of tinctures, capsules and pastilles for the nutraceutical and veterinary markets. It extracts all CBD products for adults, children, and pets. It offers a range of products, such as CBD lemon-lime sport tincture, CBD manuka honey tincture, CBD bacon flavored pet tincture, CBD softgel capsules, CBD pain relief cream, and CBD isolate powder. The Company's retail line of premium CBD extracts comes in the form of tinctures including all natural, pure hemp-derived CBD extract with raw manuka honey and all-natural, pure hemp-derived CBD extract for pets with bacon flavoring. CBD, one of the more powerful compounds in the hemp plant, binds to this system helping humans.
$0.07

Day's Change

0.0438 (166.67%)

 
I've been killed on ,y latest VIX foray, but incredibly my portfolio continues to spiral upward. Even an attempted coup didn't cause the fear index to spike. I guess I'll probably eat my losses, mostly because that huge chunk invested could be making a lot more $$ elsewhere.
When the throng of 30 year old virgins ran amuck in Congress on Wednesday would have been a good exit point for UVXY.  With Biden's coming stimulus, it'll take a big event to cause the market to tumble.  Trouble with Iran is now the most likely catalyst to a spike up.  Investing in UVXY makes me feel like this guy.

 
When the throng of 30 year old virgins ran amuck in Congress on Wednesday would have been a good exit point for UVXY.  With Biden's coming stimulus, it'll take a big event to cause the market to tumble.  Trouble with Iran is now the most likely catalyst to a spike up.  Investing in UVXY makes me feel like this guy.
It was down 50 cents on coup day. Monday was the time to sell. Hoping for a bit of profit taking / selloff on Friday afternoon to get me a better exit point. I've already sold off about 20% at around 10.20

 
FLGT down almost 15% right now. I don't own any and really aren't in the know, but I know it's been mentioned in here a bunch.

 
No..this is a penny stock that is in the ecommerce, fintech for cannabis. They are working with Hyper which is one the leading payment and banking companies. Hyper is powering Dutchie which is backed by Snoops VC firm, Casa Verde.  I've worked with these companies in the cannabis space, so I'm extremely interested. 
First they made me sign off on a bunch of penny stock forms and acknowledgements, then they send me a code to activate, but when I tried to buy 300,000 share I got the message:

(TC9052) Opening transactions for Pink Sheets (without information) are not permitted because of the risks associated with these securities and all Microcap securities.

makes sense. Some times they'll restrict me to under 5000 shares, but even if that had been the case here, I would not have made 60 transactions to do it.

Two penny stocks that have been killing it for me:

NEVDF - copper mining stock up 60%

HOFVW - warrants for HOF casino in Canton, OH. First got in around .29. At .60 now (wish I hadn't sold a bunch at .50 to lock in profits, its never taken a dip back to the 30s

 
Great to see Todem back! Welcome! Tailing you on the BLDP play - looks great - just got in. Thanks for the other recommendations as well - will look into them as time allows.

I will reiterate that folks need to seriously look at CLDR. Massive upside for this year, IMO. I'm only up 9% so far, but I see blue skies ahead.

Penny plays for those who like to partake - I really like ZOM - FDA approved device for vets to use on cats and dogs - first of its kind - I've read that every vet will eventually have one - enables them to do certain testing onsite during initial patient visit - commercialization starts in March - this one could really fly. I got the tip from my random stranger internet friend and watched it double before getting in. Not so enthusiastic but two cheaper lotto plays (can lose entire investment) are SFIO and BLPG.

 
HGEN seems to start strong and then wither away every day.  And it often trades higher in premarket trading than it will trade during market hours.  So it could be a good stock to buy in the afternoon and then sell premarket or early the next day.  It is a low risk stock since its upcoming catalysts will keep the stock price from falling much.

 
$NNOX up over 10% on reports that <flips through papers> ah, here it is: stonks go up. (I seriously have no idea why, this stock is bonkers. Hoping an FDA leak but whatever, could just be technical.)

 
DE is a core holding of mine.  :suds:

Thinking of this area, what do you think of CAT?
I always love CAT, but CAT in the $190s is a whole new world to me. I remember watching them for years range-bound in the $80s. They seem like the type of mature company in the type of industry where PE could actually still matter. So I tried to track their PE over time here, but that dip in EPS in 2017 makes the chart impossible to read.

So I ran '06-'16, in which their low looks to be sub-5 during '09 (of course), while their high is 29.42 coming out of the financial crisis. They spend most of their time in the teens. Then I ran mid-'18 to current. Mid-'18 as their earnings recovered, it came down from 24.57 June 30 to sub-teens until March '20. It has been straight up since. Currently 32.16.

So they're historically expensive. But if you believe Biden will be the President who says infrastructure and then actually does it, they've gotta be a part of that. EPS is nowhere near historic highs, so the denominator certainly has room to bring that PE down.

 
Great to see Todem back! Welcome! Tailing you on the BLDP play - looks great - just got in. Thanks for the other recommendations as well - will look into them as time allows.

I will reiterate that folks need to seriously look at CLDR. Massive upside for this year, IMO. I'm only up 9% so far, but I see blue skies ahead.
What's your catalyst on this one?

 
You don't think they'd look for a different supplier, potentially, to have a chance to differentiate themselves? Does IMMR have serious competitors?
I know you saw the post already but they have a license with MSFT already. $IMMR is the industry leader by quite a lot - some competitors, sure, but none I would call serious. Doesn't mean they won't lose some fights especially since we're still in early stages of this. 

 
With Schwab, I pay a $50 transaction fee to buy RLFTF and I pay a $50 transaction fee to sell RLFTF.  If I split it into multiple buys and multiple sells, do I pay the transaction fee for each buy and sell?  For instance, if I make 3 buys and then I make 3 sells all in the same day, will I pay $300 fees because it is 6 transactions or does it just count as 2 transactions?

 
DE seems like a stock I should own but man that thing has run. I preach waiting for a pullback to initiate a long term position is generally a bad idea but...

I might spend today looking for an infrastructure sleeper.
I came across $ALSN. Would @Lomez or @Todem or @stbugs or someone wanna take a look and give thoughts? I'm no expert at tearing apart income statements but numbers look decent. They make automatic transmissions for heavy duty vehicles, including construction. They are developing EV components (axels mainly, right now) so that's good if not critical these days. For years to come this probably needs to be more robust but they might be able to get away with for the very next upcycle.

SA article

Looks like a solid, boring as hell company that has a chance to become much less boring if we get an infrastructure boom. Just looking for something that hasn't taken off yet.

 
Last edited by a moderator:
Got my basis + a little profit out of TDOC today. Going to let the other 100 freeroll and see what they can do with the merged entity.

 
What's your catalyst on this one?
CLDR: They are finally projected to report a profit this year. Once that first ER comes out showing positive EPS, I think it will take off. I believe a lot are on the sidelines waiting for that time. Carl Icahn has a huge stake, almost 20% I think, and though he's not always right, his activist #### is heavily involved in getting them profitable. Great sales growth.

 
Last edited by a moderator:
I've been killed on ,y latest VIX foray, but incredibly my portfolio continues to spiral upward. Even an attempted coup didn't cause the fear index to spike. I guess I'll probably eat my losses, mostly because that huge chunk invested could be making a lot more $$ elsewhere.
I might as well hold through the inauguration at this point. Then I'll take my medicine. I can handle it.

 
CLDR: They are finally projected to report a profit this year. Once that first ER comes out showing positive EPS, I think it will take off. I believe a lot are on the sidelines waiting for that time. Carl Icahn has a huge stake, almost 20% I think, and though he's not always right, his activist #### is heavily involved in getting them profitable. Great sales growth.
Sounds good - in.

 
Not sure when or why I got into AVGR but it’s rolllllin
Avinger is a medical device company with its main product being Tigereye.

This is an “image-guided chronic total occlusion crossing system that can offer HD, real-time intravascular imaging to doctors.”

The device is designed to help patients suffering from Peripheral Artery Disease.

Avinger launched Tigereye in a limited release in the U.S. and Germany in the fourth quarter of 2020.

The company is planning to expand its release of the medical device in the U.S. in the first quarter of 2021.

This will have it reaching a full commercial distribution of Tigereye during this period with a national launch taking place this month.

 
With Schwab, I pay a $50 transaction fee to buy RLFTF and I pay a $50 transaction fee to sell RLFTF.  If I split it into multiple buys and multiple sells, do I pay the transaction fee for each buy and sell?  For instance, if I make 3 buys and then I make 3 sells all in the same day, will I pay $300 fees because it is 6 transactions or does it just count as 2 transactions?
6

 
I came across $ALSN. Would @Lomez or @Todem or @stbugs or someone wanna take a look and give thoughts? I'm no expert at tearing apart income statements but numbers look decent. They make automatic transmissions for heavy duty vehicles, including construction. They are developing EV components (axels mainly, right now) so that's good if not critical these days. For years to come this probably needs to be more robust but they might be able to get away with for the very next upcycle.

SA article

Looks like a solid, boring as hell company that has a chance to become much less boring if we get an infrastructure boom. Just looking for something that hasn't taken off yet.
Infrastructure AND EV seems like a good play

And the market doesn't seem to give a #### about fundamentals and balance sheets anymore

 
I came across $ALSN. Would @Lomez or @Todem or @stbugs or someone wanna take a look and give thoughts? I'm no expert at tearing apart income statements but numbers look decent. They make automatic transmissions for heavy duty vehicles, including construction. They are developing EV components (axels mainly, right now) so that's good if not critical these days. For years to come this probably needs to be more robust but they might be able to get away with for the very next upcycle.

SA article

Looks like a solid, boring as hell company that has a chance to become much less boring if we get an infrastructure boom. Just looking for something that hasn't taken off yet.
Also has a P/E under 15 and pays a 1.55% dividend.

Seems like a good candidate for a portfolio, but not for trading

 
Also has a P/E under 15 and pays a 1.55% dividend.

Seems like a good candidate for a portfolio, but not for trading
That’s what I’m looking for, anyway.

eta: looks like they don’t raise the divvy every year but they also reinvest into R&D which I’m fine with if they expand EV

 
Last edited by a moderator:
That’s what I’m looking for, anyway.

eta: looks like they don’t raise the divvy every year but they also reinvest into R&D which I’m fine with if they expand EV
Seems interesting and does highlight my thoughts that the current auto industry isn’t just rolling over and dying. Not currently my cup of tea.

 

Users who are viewing this thread

Top